The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Transition to ISO 15189 : 2012 for Cytopathology Laboratories Part 3: Risk Analysis and Management
|
|
Author(s): Eleftherios Vavoulidis (Medical School, Aristotle University of Thessaloniki and Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece), Stavros Archondakis (401 General Military Hospital of Athens, Athens, Greece), Maria Nasioutziki (Medical School, Aristotle University of Thessaloniki and Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece), Ourania Oustambasidou (401 General Military Hospital of Athens, Athens, Greece), Angelos Daniilidis (Medical School, Aristotle University of Thessaloniki and Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece), Konstantinos Dinas (Medical School, Aristotle University of Thessaloniki and Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece)and Aristotelis Loufopoulos (Medical School, Aristotle University of Thessaloniki and Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece)
Copyright: 2016
Volume: 5
Issue: 3
Pages: 20
Source title:
International Journal of Reliable and Quality E-Healthcare (IJRQEH)
Editor(s)-in-Chief: Anastasius Moumtzoglou (Hellenic Society for Quality & Safety in Healthcare and P. & A. Kyriakou Children's Hospital, Greece)
DOI: 10.4018/IJRQEH.2016070103
Purchase
|
Abstract
Modern cytopathology has advanced from the point when conventional Pap testing was adequate enough for medical diagnosis thanks to the implementation of the latest Laboratory Diagnostics. No matter how well-structured a cytopathology laboratory may be, it is still subjected to potential risks that could dramatically affect its services. Risk identification, evaluation and management via a Quality Control Plan can become a powerful tool for cytopathology laboratories wishing to maintain or/and enhance the quality of their diagnostic services. The authors present their experience on the implementation of such a risk analysis and control system covering all the necessary parameters and issues that should be addressed. Also, a hypothetical structure for a risk analysis is presented with useful guidance associated with cytological laboratories conducting morphological and molecular examinations. Finally, a mobile health solution is proposed that, if designed properly, could further optimize and harmonize risk management strategies globally.
Related Content
|
Marlon Luca Machal.
© 2024.
16 pages.
|
|
Dantong Li, Guixin Li, Shuang Li, Ashley Bang.
© 2024.
12 pages.
|
|
David Opeoluwa Oyewola, Emmanuel Gbenga Dada, Sanjay Misra.
© 2024.
21 pages.
|
|
Bin Hu, Gregory T. MacLennan.
© 2024.
11 pages.
|
|
Neetu Singh, Upkar Varshney.
© 2024.
17 pages.
|
|
Long Liu, Zhankui Zhai, Weihua Zhu.
© 2024.
10 pages.
|
|
Lucy M. Lu, Richard S. Segall.
© 2024.
18 pages.
|
|
|